Clover Biopharmaceuticals, Ltd.

Clover Biopharmaceuticals, Ltd.verified

2197.HK

Price:

$2.41

Market Cap:

$2.83B

Clover Biopharmaceuticals, Ltd., a biotechnology company, engages in the research, development, and commercialization of novel vaccines and biologic therapeutic candidates for infectious diseases, and cancer and autoimmune diseases. It is developing SCB-2019 (CpG 1018/Alum), a COVID-19 vaccine candidate that is in Phase II/III clinical trial; SCB-313, a trimeric fusion protein for the treatment of malignant ascites, malignant pleural effusions, and peritoneal carcinomatosis to address the global unmet medical need of intracavitary malignancies; SCB-808 that is in pivotal Phase III clinical trial for the treatment of rheumatic diseases; SCB-420, an aflibercept biosimilar that is in pre-clinic...[Read more]

Industry

Biotechnology

IPO Date

2021-11-05

Stock Exchange

HKSE

Ticker

2197.HK

The ROE as of December 2025 (TTM) for Clover Biopharmaceuticals, Ltd. (2197.HK) is 54.43%

According to Clover Biopharmaceuticals, Ltd.’s latest financial reports and current stock price. The company's current ROE is 54.43%. This represents a change of 24.80% compared to the average of 43.61% of the last 4 quarters.

Clover Biopharmaceuticals, Ltd. (2197.HK) Historical ROE (quarterly & annually)

How has 2197.HK ROE performed in the past?

The mean historical ROE of Clover Biopharmaceuticals, Ltd. over the last ten years is 18.71%. The current 54.43% ROE has changed 190.87% with respect to the historical average. Over the past ten years (40 quarters), 2197.HK's ROE was at its highest in in the June 2023 quarter at 2.28%. The ROE was at its lowest in in the June 2022 quarter at -643.36%.

Quarterly (TTM)
Annual

Average

18.71%

Median

63.42%

Minimum

-493.62%

Maximum

366.94%

Clover Biopharmaceuticals, Ltd. (2197.HK) ROE by Quarter and Year

Discovering the peaks and valleys of Clover Biopharmaceuticals, Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 192.05%

Maximum Annual ROE = 366.94%

Minimum Annual Increase = -629.66%

Minimum Annual ROE = -493.62%

Quarterly (TTM)
Annual
YearROEChange
202455.21%192.05%
202318.90%-94.85%
2022366.94%-174.34%
2021-493.62%-629.66%
202093.20%30.10%

Clover Biopharmaceuticals, Ltd. (2197.HK) Average ROE

How has 2197.HK ROE performed in the past?

The current ROE of Clover Biopharmaceuticals, Ltd. (2197.HK) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

147.02%

5-year avg

8.13%

10-year avg

18.71%

Clover Biopharmaceuticals, Ltd. (2197.HK) ROE vs. Peers

How is 2197.HK’s ROE compared to its peers?

Clover Biopharmaceuticals, Ltd.’s ROE is greater than Jiangsu Recbio Technology Co., Ltd. (-184.99%), greater than Antengene Corporation Limited (-28.27%), greater than Cutia Therapeutics (-54.56%), greater than HighTide Therapeutics Inc (-0.08%), greater than ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (-49.89%), less than Frontage Holdings Corporation (1.14%), greater than JW (Cayman) Therapeutics Co. Ltd (-59.45%), less than Jacobson Pharma Corporation Limited (12.32%), greater than SinoMab BioScience Limited (-66.18%), greater than Mabpharm Limited (-29.27%),

Build a custom stock screener for Clover Biopharmaceuticals, Ltd. (2197.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Clover Biopharmaceuticals, Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Clover Biopharmaceuticals, Ltd. (2197.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Clover Biopharmaceuticals, Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Clover Biopharmaceuticals, Ltd.'s ROE?

How is the ROE calculated for Clover Biopharmaceuticals, Ltd. (2197.HK)?

What is the highest ROE for Clover Biopharmaceuticals, Ltd. (2197.HK)?

What is the 3-year average ROE for Clover Biopharmaceuticals, Ltd. (2197.HK)?

What is the 5-year average ROE for Clover Biopharmaceuticals, Ltd. (2197.HK)?

How does the current ROE for Clover Biopharmaceuticals, Ltd. (2197.HK) compare to its historical average?